021-51111890
购物车（）
sales@molnova.cn
Regorafenib
CAS No. 755037-03-7
Regorafenib ( BAY 73-4506;BAY73-4506 )
产品货号. M15869 CAS No. 755037-03-7
A potent multikinase inhibitor that potently inhibits these endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥243 | 有现货 |
|
| 10MG | ￥381 | 有现货 |
|
| 25MG | ￥591 | 有现货 |
|
| 50MG | ￥786 | 有现货 |
|
| 100MG | ￥1191 | 有现货 |
|
| 200MG | ￥1580 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Regorafenib
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述A potent multikinase inhibitor that potently inhibits these endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM).
-
产品描述A potent multikinase inhibitor that potently inhibits these endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM); inhibits VEGFR1/2/3, PDGFRβ, FGFR1, KIT, RET and B-RAF etc.; exhibits potent dose-dependent TGI in various preclinical human xenograft models in mice; orally active.Colon Cancer Approved
-
同义词BAY 73-4506;BAY73-4506
-
通路Angiogenesis
-
靶点VEGFR
-
受体Kit;Raf-1;RET;VEGFR1;VEGFR2;B-Raf(V600E)
-
研究领域Cancer
-
适应症Colon Cancer
化学信息
-
CAS Number755037-03-7
-
分子量482.82
-
分子式C21H15ClF4N4O3
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 260 mg/mL
-
SMILESC12=NC(NC3=CC=C(N4CCOCC4)C=C3)=NC(NC5CCCCC5)=C1NC=N2
-
化学全称2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
2. Mross K, et al. Clin Cancer Res. 2012 May 1;18(9):2658-67.
3. Abou-Elkacem L, et al. Mol Cancer Ther. 2013 Jul;12(7):1322-31.
产品手册
